Critical point (thermodynamics)

From Wikipedia, the free encyclopedia

https://en.wikipedia.org/wiki/Critical_point_(thermodynamics) 

1. Subcritical ethane, liquid and gas phase coexist.
2. Critical point (32.17 °C, 48.72 bar), opalescence.
3. Supercritical ethane, fluid.

In thermodynamics, a critical point (or critical state) is the end point of a phase equilibrium curve. The most prominent example is the liquid–vapor critical point, the end point of the pressure–temperature curve that designates conditions under which a liquid and its vapor can coexist. At higher temperatures, the gas cannot be liquefied by pressure alone. At the critical point, defined by a critical temperature T_c and a critical pressure p_c, phase boundaries vanish. Other examples include the liquid–liquid critical points in mixtures, and the ferromagnet-paramagnet transition in the absence of an external magnetic field.

Liquid–vapor critical point

Overview

The liquid–vapor critical point in a pressure–temperature phase diagram is at the high-temperature extreme of the liquid–gas phase boundary. The dashed green line shows the anomalous behavior of water.

For simplicity and clarity, the generic notion of critical point is best introduced by discussing a specific example, the vapor-liquid critical point. This was the first critical point to be discovered, and it is still the best known and most studied one.

The figure to the right shows the schematic PT diagram of a pure substance (as opposed to mixtures, which have additional state variables and richer phase diagrams, discussed below). The commonly known phases solid, liquid and vapor are separated by phase boundaries, i.e. pressure–temperature combinations where two phases can coexist. At the triple point, all three phases can coexist. However, the liquid–vapor boundary terminates in an endpoint at some critical temperature T_c and critical pressure p_c. This is the critical point.

In water, the critical point occurs at 647.096 K (373.946 °C; 705.103 °F) and 22.064 megapascals (3,200.1 psi; 217.75 atm).

In the vicinity of the critical point, the physical properties of the liquid and the vapor change dramatically, with both phases becoming ever more similar. For instance, liquid water under normal conditions is nearly incompressible, has a low thermal expansion coefficient, has a high dielectric constant, and is an excellent solvent for electrolytes. Near the critical point, all these properties change into the exact opposite: water becomes compressible, expandable, a poor dielectric, a bad solvent for electrolytes, and prefers to mix with nonpolar gases and organic molecules.

At the critical point, only one phase exists. The heat of vaporization is zero. There is a stationary inflection point in the constant-temperature line (critical isotherm) on a PV diagram. This means that at the critical point:

${\displaystyle \left({\frac {\partial p}{\partial V}}\right)_{T}=0,}$

${\displaystyle \left({\frac {\partial ^{2}p}{\partial V^{2}}}\right)_{T}=0.}$

The critical isotherm with the critical point K

Above the critical point there exists a state of matter that is continuously connected with (can be transformed without phase transition into) both the liquid and the gaseous state. It is called supercritical fluid. The common textbook knowledge that all distinction between liquid and vapor disappears beyond the critical point has been challenged by Fisher and Widom, who identified a p–T line that separates states with different asymptotic statistical properties (Fisher–Widom line).

Sometimes the critical point does not manifest in most thermodynamic or mechanical properties, but is "hidden" and reveals itself in the onset of inhomogeneities in elastic moduli, marked changes in the appearance and local properties of non-affine droplets, and a sudden enhancement in defect pair concentration.

History

Critical carbon dioxide exuding fog while cooling from supercritical to critical temperature.

The existence of a critical point was first discovered by Charles Cagniard de la Tour in 1822 and named by Dmitri Mendeleev in 1860 and Thomas Andrews in 1869. Cagniard showed that CO₂ could be liquefied at 31 °C at a pressure of 73 atm, but not at a slightly higher temperature, even under pressures as high as 3000 atm.

Theory

Solving the above condition ${\displaystyle (\partial p/\partial V)_{T}=0}$ for the van der Waals equation, one can compute the critical point as

${\displaystyle T_{\text{c}}={\frac {8a}{27Rb}},\quad V_{\text{c}}=3nb,\quad p_{\text{c}}={\frac {a}{27b^{2}}}.}$

However, the van der Waals equation, based on a mean-field theory, does not hold near the critical point. In particular, it predicts wrong scaling laws.

To analyse properties of fluids near the critical point, reduced state variables are sometimes defined relative to the critical properties

${\displaystyle T_{\text{r}}={\frac {T}{T_{\text{c}}}},\quad p_{\text{r}}={\frac {p}{p_{\text{c}}}},\quad V_{\text{r}}={\frac {V}{RT_{\text{c}}/p_{\text{c}}}}.}$

The principle of corresponding states indicates that substances at equal reduced pressures and temperatures have equal reduced volumes. This relationship is approximately true for many substances, but becomes increasingly inaccurate for large values of p_r.

For some gases, there is an additional correction factor, called Newton's correction, added to the critical temperature and critical pressure calculated in this manner. These are empirically derived values and vary with the pressure range of interest.

Table of liquid–vapor critical temperature and pressure for selected substances

See also: Critical points of the elements (data page)

 

Substance	Critical temperature	Critical pressure (absolute)
Argon	−122.4 °C (150.8 K)	48.1 atm (4,870 kPa)
Ammonia (NH3)	132.4 °C (405.5 K)	111.3 atm (11,280 kPa)
R-134a	101.06 °C (374.21 K)	40.06 atm (4,059 kPa)
R-410A	72.8 °C (345.9 K)	47.08 atm (4,770 kPa)
Bromine	310.8 °C (584.0 K)	102 atm (10,300 kPa)
Caesium	1,664.85 °C (1,938.00 K)	94 atm (9,500 kPa)
Chlorine	143.8 °C (416.9 K)	76.0 atm (7,700 kPa)
Ethanol (C2H5OH)	241 °C (514 K)	62.18 atm (6,300 kPa)
Fluorine	−128.85 °C (144.30 K)	51.5 atm (5,220 kPa)
Helium	−267.96 °C (5.19 K)	2.24 atm (227 kPa)
Hydrogen	−239.95 °C (33.20 K)	12.8 atm (1,300 kPa)
Krypton	−63.8 °C (209.3 K)	54.3 atm (5,500 kPa)
Methane (CH4)	−82.3 °C (190.8 K)	45.79 atm (4,640 kPa)
Neon	−228.75 °C (44.40 K)	27.2 atm (2,760 kPa)
Nitrogen	−146.9 °C (126.2 K)	33.5 atm (3,390 kPa)
Oxygen (O2)	−118.6 °C (154.6 K)	49.8 atm (5,050 kPa)
Carbon dioxide (CO2)	31.04 °C (304.19 K)	72.8 atm (7,380 kPa)
Nitrous oxide (N2O)	36.4 °C (309.5 K)	71.5 atm (7,240 kPa)
Sulfuric acid (H2SO4)	654 °C (927 K)	45.4 atm (4,600 kPa)
Xenon	16.6 °C (289.8 K)	57.6 atm (5,840 kPa)
Lithium	2,950 °C (3,220 K)	652 atm (66,100 kPa)
Mercury	1,476.9 °C (1,750.1 K)	1,720 atm (174,000 kPa)
Sulfur	1,040.85 °C (1,314.00 K)	207 atm (21,000 kPa)
Iron	8,227 °C (8,500 K)
Gold	6,977 °C (7,250 K)	5,000 atm (510,000 kPa)
Aluminium	7,577 °C (7,850 K)
Water (H2O)	373.946 °C (647.096 K)	217.7 atm (22,060 kPa)

Mixtures: liquid–liquid critical point

A plot of typical polymer solution phase behavior including two critical points: a LCST and an UCST

The liquid–liquid critical point of a solution, which occurs at the critical solution temperature, occurs at the limit of the two-phase region of the phase diagram. In other words, it is the point at which an infinitesimal change in some thermodynamic variable (such as temperature or pressure) leads to separation of the mixture into two distinct liquid phases, as shown in the polymer–solvent phase diagram to the right. Two types of liquid–liquid critical points are the upper critical solution temperature (UCST), which is the hottest point at which cooling induces phase separation, and the lower critical solution temperature (LCST), which is the coldest point at which heating induces phase separation.

Mathematical definition

From a theoretical standpoint, the liquid–liquid critical point represents the temperature–concentration extremum of the spinodal curve (as can be seen in the figure to the right). Thus, the liquid–liquid critical point in a two-component system must satisfy two conditions: the condition of the spinodal curve (the second derivative of the free energy with respect to concentration must equal zero), and the extremum condition (the third derivative of the free energy with respect to concentration must also equal zero or the derivative of the spinodal temperature with respect to concentration must equal zero).

Anemia

From Wikipedia, the free encyclopedia

https://en.wikipedia.org/wiki/Anemia 

Anemia
Other names	Anaemia, erythrocytopenia
Blood smear from a person with iron-deficiency anemia. Note the red cells are small and pale.
Pronunciation	/əˈniːmiə/
Specialty	Hematology
Symptoms	Feeling tired, pale skin, weakness, shortness of breath, feeling like passing out
Causes	Bleeding, decreased red blood cell production, increased red blood cell breakdown
Diagnostic method	Blood hemoglobin measurement
Frequency	2.36 billion / 33% (2015)

Anemia, also spelled anaemia and sometimes called erythrocytopenia, is a condition in which the blood has a lower than normal number of red blood cells (RBCs) or hemoglobin, or a lowered ability of the blood to carry oxygen. When anemia comes on slowly, the symptoms are often vague, such as feeling tired, weakness, shortness of breath, headaches, and a poor ability to exercise. When the anemia comes on quickly, symptoms may include confusion, feeling like passing out, loss of consciousness, and increased thirst. Anemia must be significant before a person becomes noticeably pale. Additional symptoms may occur depending on the underlying cause. For people who require surgery, pre-operative anemia can increase the risk of requiring a blood transfusion following surgery.

Anemia can be caused by bleeding, decreased red blood cell production, and increased red blood cell breakdown. Causes of bleeding include trauma and gastrointestinal bleeding. Causes of decreased production include iron deficiency, vitamin B12 deficiency, thalassemia and a number of neoplasms of the bone marrow. Causes of increased breakdown include genetic conditions such as sickle cell anemia, infections such as malaria, and certain autoimmune diseases. Anemia can also be classified based on the size of the red blood cells and amount of hemoglobin in each cell. If the cells are small, it is called microcytic anemia; if they are large, it is called macrocytic anemia; and if they are normal sized, it is called normocytic anemia. The diagnosis of anemia in men is based on a hemoglobin of less than 130 to 140 g/L (13 to 14 g/dL); in women, it is less than 120 to 130 g/L (12 to 13 g/dL). Further testing is then required to determine the cause.

Certain groups of individuals, such as pregnant women, benefit from the use of iron pills for prevention. Dietary supplementation, without determining the specific cause, is not recommended. The use of blood transfusions is typically based on a person's signs and symptoms. In those without symptoms, they are not recommended unless hemoglobin levels are less than 60 to 80 g/L (6 to 8 g/dL). These recommendations may also apply to some people with acute bleeding. Erythropoiesis-stimulating agents are only recommended in those with severe anemia.

Anemia is the most common blood disorder, affecting about a third of the global population. Iron-deficiency anemia affects nearly 1 billion people. In 2013, anemia due to iron deficiency resulted in about 183,000 deaths – down from 213,000 deaths in 1990. This condition is more common in women than men, during pregnancy, and in children and the elderly. Anemia increases costs of medical care and lowers a person's productivity through a decreased ability to work. The name is derived from Ancient Greek: ἀναιμία anaimia, meaning "lack of blood", from ἀν- an-, "not" and αἷμα haima, "blood".

Anemia is one of the six WHO global nutrition targets for 2025 and diet-related global NCD targets for 2025, endorsed by World Health Assembly in 2012 and 2013. Efforts to reach global targets contribute to reaching Sustainable Development Goals (SDGs), with anemia as one of the targets in SDG 2.

Signs and symptoms

Main symptoms that may appear in anemia

 

The hand of a person with severe anemia (on the left, with ring) compared to one without (on the right)

Anemia is considered as the most common blood disorder, a person with anemia may not have any symptoms depending on the underlying cause, and no symptoms may be noticed, as the anemia is initially minor, and then the symptoms become worse as the anemia worsens. A patient with anemia may report feeling tired, weak, decreased ability to concentrate, and sometimes shortness of breath on exertion.

If the anemia come on quickly, the symptoms often may include, feeling like one is going to pass out, confusion, chest pain, and increased thirst—but if the anemia continues slowly (chronic), the body may adapt and compensate for this change; in this case, no symptoms may appear until the anemia becomes more severe. If a person becomes anemic, a set of sign and symptoms may occur, such as feeling tired, weak, feeling like passing out, dizziness, headaches, lack of physical exertion (accompanied by shortness of breath and rapid heartbeat), breathlessness (rapid), difficulty concentrating, irregular heartbeat (fluttering, or rapid heartbeat), cold hands and feet, chest pain, constantly feeling cold, soreness of the tongue, pallor, nausea, poor appetite, easy bruising and bleeding, and muscle weakness.

In more severe anemia, the body may compensate for the lack of oxygen-carrying capability of the blood by increasing cardiac output. The person may have symptoms related to this, such as palpitations, angina (if pre-existing heart disease is present), intermittent claudication of the legs, and symptoms of heart failure. On examination, the signs exhibited may include pallor (pale skin, mucosa, conjunctiva and nail beds), but this is not a reliable sign. A blue coloration of the sclera may be noticed in some cases of iron-deficiency anemia. There may be signs of specific causes of anemia, e.g. koilonychia (in iron deficiency), jaundice (when anemia results from abnormal break down of red blood cells – in hemolytic anemia), nerve cell damage (vitamin B₁₂ deficiency), bone deformities (found in thalassemia major) or leg ulcers (seen in sickle-cell disease). In severe anemia, there may be signs of a hyperdynamic circulation: tachycardia (a fast heart rate), bounding pulse, flow murmurs, and cardiac ventricular hypertrophy (enlargement). There may be signs of heart failure. Pica, the consumption of non-food items such as ice, but also paper, wax, or grass, and even hair or dirt, may be a symptom of iron deficiency, although it occurs often in those who have normal levels of hemoglobin. Chronic anemia may result in behavioral disturbances in children as a direct result of impaired neurological development in infants, and reduced academic performance in children of school age. Restless legs syndrome is more common in people with iron-deficiency anemia than in the general population.

Causes

Figure shows normal red blood cells flowing freely in a blood vessel. The inset image shows a cross-section of a normal red blood cell with normal hemoglobin.

The causes of anemia may be classified as impaired red blood cell (RBC) production, increased RBC destruction (hemolytic anemias), blood loss and fluid overload (hypervolemia). Several of these may interplay to cause anemia. The most common cause of anemia is blood loss, but this usually does not cause any lasting symptoms unless a relatively impaired RBC production develops, in turn, most commonly by iron deficiency.

Impaired production

• Disturbance of proliferation and differentiation of stem cells
  • Pure red cell aplasia
  • Aplastic anemia affects all kinds of blood cells. Fanconi anemia is a hereditary disorder or defect featuring aplastic anemia and various other abnormalities.
  • Anemia of kidney failure due to insufficient production of the hormone erythropoietin
  • Anemia of endocrine disease
• Disturbance of proliferation and maturation of erythroblasts
  • Pernicious anemia is a form of megaloblastic anemia due to vitamin B₁₂ deficiency dependent on impaired absorption of vitamin B₁₂. Lack of dietary B₁₂ causes non-pernicious megaloblastic anemia.
  • Anemia of folate deficiency, as with vitamin B₁₂, causes megaloblastic anemia
  • Anemia of prematurity, by diminished erythropoietin response to declining hematocrit levels, combined with blood loss from laboratory testing, generally occurs in premature infants at two to six weeks of age.
  • Iron deficiency anemia, resulting in deficient heme synthesis
  • Thalassemias, causing deficient globin synthesis
  • Congenital dyserythropoietic anemias, causing ineffective erythropoiesis
  • Anemia of kidney failure (also causing stem cell dysfunction)
• Other mechanisms of impaired RBC production
  • Myelophthisic anemia or myelophthisis is a severe type of anemia resulting from the replacement of bone marrow by other materials, such as malignant tumors, fibrosis, or granulomas.
  • Myelodysplastic syndrome
  • anemia of chronic inflammation
  • Leukoerythroblastic anemia is caused by space-occupying lesions in the bone marrow that prevent normal production of blood cells.

Increased destruction

Further information: Hemolytic anemia

Anemias of increased red blood cell destruction are generally classified as hemolytic anemias. These are generally featuring jaundice and elevated lactate dehydrogenase levels.

• Intrinsic (intracorpuscular) abnormalities cause premature destruction. All of these, except paroxysmal nocturnal hemoglobinuria, are hereditary genetic disorders.
  • Hereditary spherocytosis is a hereditary defect that results in defects in the RBC cell membrane, causing the erythrocytes to be sequestered and destroyed by the spleen.
  • Hereditary elliptocytosis is another defect in membrane skeleton proteins.
  • Abetalipoproteinemia, causing defects in membrane lipids
  • Enzyme deficiencies
    • Pyruvate kinase and hexokinase deficiencies, causing defect glycolysis
    • Glucose-6-phosphate dehydrogenase deficiency and glutathione synthetase deficiency, causing increased oxidative stress
  • Hemoglobinopathies
    • Sickle cell anemia
    • Hemoglobinopathies causing unstable hemoglobins
  • Paroxysmal nocturnal hemoglobinuria
• Extrinsic (extracorpuscular) abnormalities
  • Antibody-mediated
    • Warm autoimmune hemolytic anemia is caused by autoimmune attack against red blood cells, primarily by IgG. It is the most common of the autoimmune hemolytic diseases. It can be idiopathic, that is, without any known cause, drug-associated or secondary to another disease such as systemic lupus erythematosus, or a malignancy, such as chronic lymphocytic leukemia.
    • Cold agglutinin hemolytic anemia is primarily mediated by IgM. It can be idiopathic or result from an underlying condition.
    • Rh disease, one of the causes of hemolytic disease of the newborn
    • Transfusion reaction to blood transfusions
  • Mechanical trauma to red blood cells
    • Microangiopathic hemolytic anemias, including thrombotic thrombocytopenic purpura and disseminated intravascular coagulation
    • Infections, including malaria
    • Heart surgery
    • Haemodialysis

Blood loss

• Anemia of prematurity, from frequent blood sampling for laboratory testing, combined with insufficient RBC production
• Trauma or surgery, causing acute blood loss
• Gastrointestinal tract lesions, causing either acute bleeds (e.g. variceal lesions, peptic ulcers) or chronic blood loss (e.g. angiodysplasia)
• Gynecologic disturbances, also generally causing chronic blood loss
• From menstruation, mostly among young women or older women who have fibroids
• Many type of cancers, including colorectal cancer and cancer of the urinary bladder, may cause acute or chronic blood loss, especially at advanced stages
• Infection by intestinal nematodes feeding on blood, such as hookworms and the whipworm Trichuris trichiura 
• Iatrogenic anemia, blood loss from repeated blood draws and medical procedures.

The roots of the words anemia and ischemia both refer to the basic idea of "lack of blood", but anemia and ischemia are not the same thing in modern medical terminology. The word anemia used alone implies widespread effects from blood that either is too scarce (e.g., blood loss) or is dysfunctional in its oxygen-supplying ability (due to whatever type of hemoglobin or erythrocyte problem). In contrast, the word ischemia refers solely to the lack of blood (poor perfusion). Thus ischemia in a body part can cause localized anemic effects within those tissues.

Fluid overload

Fluid overload (hypervolemia) causes decreased hemoglobin concentration and apparent anemia:

• General causes of hypervolemia include excessive sodium or fluid intake, sodium or water retention and fluid shift into the intravascular space.
• From the 6th week of pregnancy, hormonal changes cause an increase in the mother's blood volume due to an increase in plasma.

Intestinal inflammation

Certain gastrointestinal disorders can cause anemia. The mechanisms involved are multifactorial and not limited to malabsorption but mainly related to chronic intestinal inflammation, which causes dysregulation of hepcidin that leads to decreased access of iron to the circulation.

• Helicobacter pylori infection.
• Gluten-related disorders: untreated celiac disease and non-celiac gluten sensitivity. Anemia can be the only manifestation of celiac disease, in absence of gastrointestinal or any other symptoms.
• Inflammatory bowel disease.

Diagnosis

Peripheral blood smear microscopy of a patient with iron-deficiency anemia

 

A Giemsa-stained blood film from a person with iron-deficiency anemia. This person also had hemoglobin Kenya.

Definitions

There are a number of definitions of anemia; reviews provide comparison and contrast of them. A strict but broad definition is an absolute decrease in red blood cell mass, however, a broader definition is a lowered ability of the blood to carry oxygen. An operational definition is a decrease in whole-blood hemoglobin concentration of more than 2 standard deviations below the mean of an age- and sex-matched reference range.

It is difficult to directly measure RBC mass, so the hematocrit (amount of RBCs) or the hemoglobin (Hb) in the blood are often used instead to indirectly estimate the value. Hematocrit; however, is concentration dependent and is therefore not completely accurate. For example, during pregnancy a woman's RBC mass is normal but because of an increase in blood volume the hemoglobin and hematocrit are diluted and thus decreased. Another example would be bleeding where the RBC mass would decrease but the concentrations of hemoglobin and hematocrit initially remains normal until fluids shift from other areas of the body to the intravascular space.

The anemia is also classified by severity into mild (110 g/L to normal), moderate (80 g/L to 110 g/L), and severe anemia (less than 80 g/L) in adult males and adult non pregnant females. Different values are used in pregnancy and children.

Testing

Anemia is typically diagnosed on a complete blood count. Apart from reporting the number of red blood cells and the hemoglobin level, the automatic counters also measure the size of the red blood cells by flow cytometry, which is an important tool in distinguishing between the causes of anemia. Examination of a stained blood smear using a microscope can also be helpful, and it is sometimes a necessity in regions of the world where automated analysis is less accessible.

WHO's Hemoglobin thresholds used to define anemia (1 g/dL = 0.6206 mmol/L)

Age or gender group	Hb threshold (g/dl)	Hb threshold (mmol/l)
Children (0.5–5.0 yrs)	11.0	6.8
Children (5–12 yrs)	11.5	7.1
Teens (12–15 yrs)	12.0	7.4
Women, non-pregnant (>15yrs)	12.0	7.4
Women, pregnant	11.0	6.8
Men (>15yrs)	13.0	8.1

A blood test will provide counts of white blood cells, red blood cells and platelets. If anemia appears, further tests may determine what type it is, and whether it has a serious cause. although of that, it is possible to refer to the genetic history and physical diagnosis. These tests may include:

• complete blood count (CBC); a CBC is used to count the number of blood cells in a sample of the blood. For anemia, it will likely to be interested in the levels of the red blood cells contained in blood (hematocrit), hemoglobin, mean corpuscular volume.
• determine the size and shape of red blood cells; some of red blood cells might also be examined for unusual size, shape and color.
• serum ferritin; This protein helps store iron in the body, a low levels of ferritin usually indicates a low levels of stored iron.
• serum vitamin B₁₂; low levels usually develop an anemia, vitamin B₁₂ is needed to make red blood cells, which carry oxygen to all parts of human body.
• blood tests to detect rare causes; such as an immune attack on red blood cells, red blood cell fragility, and defects of enzymes, hemoglobin, and clotting.
• a bone marrow sample; when the cause is unclear, a bone marrow test is performed, most often, when some blood cell defect is suspected.

Reticulocyte counts, and the "kinetic" approach to anemia, have become more common than in the past in the large medical centers of the United States and some other wealthy nations, in part because some automatic counters now have the capacity to include reticulocyte counts. A reticulocyte count is a quantitative measure of the bone marrow's production of new red blood cells. The reticulocyte production index is a calculation of the ratio between the level of anemia and the extent to which the reticulocyte count has risen in response. If the degree of anemia is significant, even a "normal" reticulocyte count actually may reflect an inadequate response. If an automated count is not available, a reticulocyte count can be done manually following special staining of the blood film. In manual examination, activity of the bone marrow can also be gauged qualitatively by subtle changes in the numbers and the morphology of young RBCs by examination under a microscope. Newly formed RBCs are usually slightly larger than older RBCs and show polychromasia. Even where the source of blood loss is obvious, evaluation of erythropoiesis can help assess whether the bone marrow will be able to compensate for the loss and at what rate. When the cause is not obvious, clinicians use other tests, such as: ESR, serum iron, transferrin, RBC folate level, hemoglobin electrophoresis, renal function tests (e.g. serum creatinine) although the tests will depend on the clinical hypothesis that is being investigated. When the diagnosis remains difficult, a bone marrow examination allows direct examination of the precursors to red cells, although is rarely used as is painful, invasive and is hence reserved for cases where severe pathology needs to be determined or excluded.

Red blood cell size

In the morphological approach, anemia is classified by the size of red blood cells; this is either done automatically or on microscopic examination of a peripheral blood smear. The size is reflected in the mean corpuscular volume (MCV). If the cells are smaller than normal (under 80 fl), the anemia is said to be microcytic; if they are normal size (80–100 fl), normocytic; and if they are larger than normal (over 100 fl), the anemia is classified as macrocytic. This scheme quickly exposes some of the most common causes of anemia; for instance, a microcytic anemia is often the result of iron deficiency. In clinical workup, the MCV will be one of the first pieces of information available, so even among clinicians who consider the "kinetic" approach more useful philosophically, morphology will remain an important element of classification and diagnosis. Limitations of MCV include cases where the underlying cause is due to a combination of factors – such as iron deficiency (a cause of microcytosis) and vitamin B12 deficiency (a cause of macrocytosis) where the net result can be normocytic cells.

Production vs. destruction or loss

The "kinetic" approach to anemia yields arguably the most clinically relevant classification of anemia. This classification depends on evaluation of several hematological parameters, particularly the blood reticulocyte (precursor of mature RBCs) count. This then yields the classification of defects by decreased RBC production versus increased RBC destruction or loss. Clinical signs of loss or destruction include abnormal peripheral blood smear with signs of hemolysis; elevated LDH suggesting cell destruction; or clinical signs of bleeding, such as guaiac-positive stool, radiographic findings, or frank bleeding.

Other characteristics visible on the peripheral smear may provide valuable clues about a more specific diagnosis; for example, abnormal white blood cells may point to a cause in the bone marrow.

Microcytic

Main article: Microcytic anemia

Microcytic anemia is primarily a result of hemoglobin synthesis failure/insufficiency, which could be caused by several etiologies:

• Heme synthesis defect
  • Iron deficiency anemia (microcytosis is not always present)
  • Anemia of chronic disease (more commonly presenting as normocytic anemia)
• Globin synthesis defect
  • Alpha-, and beta-thalassemia
  • HbE syndrome
  • HbC syndrome
  • Various other unstable hemoglobin diseases
• Sideroblastic defect
  • Hereditary sideroblastic anemia
  • Acquired sideroblastic anemia, including lead toxicity
  • Reversible sideroblastic anemia

Iron deficiency anemia is the most common type of anemia overall and it has many causes. RBCs often appear hypochromic (paler than usual) and microcytic (smaller than usual) when viewed with a microscope.

• Iron deficiency anemia is due to insufficient dietary intake or absorption of iron to meet the body's needs. Infants, toddlers, and pregnant women have higher than average needs. Increased iron intake is also needed to offset blood losses due to digestive tract issues, frequent blood donations, or heavy menstrual periods. Iron is an essential part of hemoglobin, and low iron levels result in decreased incorporation of hemoglobin into red blood cells. In the United States, 12% of all women of childbearing age have iron deficiency, compared with only 2% of adult men. The incidence is as high as 20% among African American and Mexican American women. Studies have shown iron deficiency without anemia causes poor school performance and lower IQ in teenage girls, although this may be due to socioeconomic factors. Iron deficiency is the most prevalent deficiency state on a worldwide basis. It is sometimes the cause of abnormal fissuring of the angular (corner) sections of the lips (angular stomatitis).
• In the United States, the most common cause of iron deficiency is bleeding or blood loss, usually from the gastrointestinal tract. Fecal occult blood testing, upper endoscopy and lower endoscopy should be performed to identify bleeding lesions. In older men and women, the chances are higher that bleeding from the gastrointestinal tract could be due to colon polyps or colorectal cancer.
• Worldwide, the most common cause of iron deficiency anemia is parasitic infestation (hookworms, amebiasis, schistosomiasis and whipworms).

The Mentzer index (mean cell volume divided by the RBC count) predicts whether microcytic anemia may be due to iron deficiency or thalassemia, although it requires confirmation.

Macrocytic

Main article: Macrocytic anemia

• Megaloblastic anemia, the most common cause of macrocytic anemia, is due to a deficiency of either vitamin B₁₂, folic acid, or both. Deficiency in folate or vitamin B₁₂ can be due either to inadequate intake or insufficient absorption. Folate deficiency normally does not produce neurological symptoms, while B₁₂ deficiency does.
  • Pernicious anemia is caused by a lack of intrinsic factor, which is required to absorb vitamin B₁₂ from food. A lack of intrinsic factor may arise from an autoimmune condition targeting the parietal cells (atrophic gastritis) that produce intrinsic factor or against intrinsic factor itself. These lead to poor absorption of vitamin B₁₂.
  • Macrocytic anemia can also be caused by the removal of the functional portion of the stomach, such as during gastric bypass surgery, leading to reduced vitamin B₁₂/folate absorption. Therefore, one must always be aware of anemia following this procedure.
• Hypothyroidism
• Alcoholism commonly causes a macrocytosis, although not specifically anemia. Other types of liver disease can also cause macrocytosis.
• Drugs such as methotrexate, zidovudine, and other substances may inhibit DNA replication such as heavy metals

Macrocytic anemia can be further divided into "megaloblastic anemia" or "nonmegaloblastic macrocytic anemia". The cause of megaloblastic anemia is primarily a failure of DNA synthesis with preserved RNA synthesis, which results in restricted cell division of the progenitor cells. The megaloblastic anemias often present with neutrophil hypersegmentation (six to 10 lobes). The nonmegaloblastic macrocytic anemias have different etiologies (i.e. unimpaired DNA globin synthesis,) which occur, for example, in alcoholism. In addition to the nonspecific symptoms of anemia, specific features of vitamin B₁₂ deficiency include peripheral neuropathy and subacute combined degeneration of the cord with resulting balance difficulties from posterior column spinal cord pathology. Other features may include a smooth, red tongue and glossitis. The treatment for vitamin B₁₂-deficient anemia was first devised by William Murphy, who bled dogs to make them anemic, and then fed them various substances to see what (if anything) would make them healthy again. He discovered that ingesting large amounts of liver seemed to cure the disease. George Minot and George Whipple then set about to isolate the curative substance chemically and ultimately were able to isolate the vitamin B₁₂ from the liver. All three shared the 1934 Nobel Prize in Medicine.

Normocytic

Main article: Normocytic anemia

Normocytic anemia occurs when the overall hemoglobin levels are decreased, but the red blood cell size (mean corpuscular volume) remains normal. Causes include:

• Acute blood loss
• Anemia of chronic disease
• Aplastic anemia (bone marrow failure)
• Hemolytic anemia

Dimorphic

A dimorphic appearance on a peripheral blood smear occurs when there are two simultaneous populations of red blood cells, typically of different size and hemoglobin content (this last feature affecting the color of the red blood cell on a stained peripheral blood smear). For example, a person recently transfused for iron deficiency would have small, pale, iron deficient red blood cells (RBCs) and the donor RBCs of normal size and color. Similarly, a person transfused for severe folate or vitamin B12 deficiency would have two cell populations, but, in this case, the patient's RBCs would be larger and paler than the donor's RBCs. A person with sideroblastic anemia (a defect in heme synthesis, commonly caused by alcoholism, but also drugs/toxins, nutritional deficiencies, a few acquired and rare congenital diseases) can have a dimorphic smear from the sideroblastic anemia alone. Evidence for multiple causes appears with an elevated RBC distribution width (RDW), indicating a wider-than-normal range of red cell sizes, also seen in common nutritional anemia.

Heinz body anemia

Heinz bodies form in the cytoplasm of RBCs and appear as small dark dots under the microscope. In animals, Heinz body anemia has many causes. It may be drug-induced, for example in cats and dogs by acetaminophen (paracetamol), or may be caused by eating various plants or other substances:

• In cats and dogs after eating either raw or cooked plants from the genus Allium, for example, onions or garlic.
• In dogs after ingestion of zinc, for example, after eating U.S. pennies minted after 1982.
• In horses which eat dry or wilted red maple leaves.

Hyperanemia

Hyperanemia is a severe form of anemia, in which the hematocrit is below 10%.

Refractory anemia

Refractory anemia, an anemia which does not respond to treatment, is often seen secondary to myelodysplastic syndromes. Iron deficiency anemia may also be refractory as a manifestation of gastrointestinal problems which disrupt iron absorption or cause occult bleeding. 

Transfusion dependent

Transfusion dependent anemia is a form of anemia where ongoing blood transfusion are required. Most people with myelodysplastic syndrome develop this state at some point in time. Beta thalassemia may also result in transfusion dependence. Concerns from repeated blood transfusions include iron overload. This iron overload may require chelation therapy.

Treatment

Treatment for anemia depends on cause and severity. Vitamin supplements given orally (folic acid or vitamin B₁₂) or intramuscularly (vitamin B₁₂) will replace specific deficiencies.

Oral iron

Nutritional iron deficiency is common in developing nations. An estimated two-thirds of children and of women of childbearing age in most developing nations are estimated to have iron deficiency without anemia; one-third of them have iron deficiency with anemia. Iron deficiency due to inadequate dietary iron intake is rare in men and postmenopausal women. The diagnosis of iron deficiency mandates a search for potential sources of blood loss, such as gastrointestinal bleeding from ulcers or colon cancer.

Mild to moderate iron-deficiency anemia is treated by oral iron supplementation with ferrous sulfate, ferrous fumarate, or ferrous gluconate. Daily iron supplements have been shown to be effective in reducing anemia in women of childbearing age. When taking iron supplements, stomach upset or darkening of the feces are commonly experienced. The stomach upset can be alleviated by taking the iron with food; however, this decreases the amount of iron absorbed. Vitamin C aids in the body's ability to absorb iron, so taking oral iron supplements with orange juice is of benefit.

In the anemia of chronic kidney disease, recombinant erythropoietin or epoetin alfa is recommended to stimulate RBC production, and if iron deficiency and inflammation are also present, concurrent parenteral iron is also recommended.

Injectable iron

In cases where oral iron has either proven ineffective, would be too slow (for example, pre-operatively), or where absorption is impeded (for example in cases of inflammation), parenteral iron preparations can be used. Parenteral iron can improve iron stores rapidly and is also effective for treating people with postpartum haemorrhage, inflammatory bowel disease, and chronic heart failure. The body can absorb up to 6 mg iron daily from the gastrointestinal tract. In many cases, the patient has a deficit of over 1,000 mg of iron which would require several months to replace. This can be given concurrently with erythropoietin to ensure sufficient iron for increased rates of erythropoiesis.

Blood transfusions

Blood transfusions in those without symptoms is not recommended until the hemoglobin is below 60 to 80 g/L (6 to 8 g/dL). In those with coronary artery disease who are not actively bleeding transfusions are only recommended when the hemoglobin is below 70 to 80g/L (7 to 8 g/dL). Transfusing earlier does not improve survival. Transfusions otherwise should only be undertaken in cases of cardiovascular instability.

A 2012 review concluded that when considering blood transfusions for anaemia in people with advanced cancer who have fatigue and breathlessness (not related to cancer treatment or haemorrhage), consideration should be given to whether there are alternative strategies can be tried before a blood transfusion.

Erythropoiesis-stimulating agents

The objective for the administration of an erythropoiesis-stimulating agent (ESA) is to maintain hemoglobin at the lowest level that both minimizes transfusions and meets the individual person's needs. They should not be used for mild or moderate anemia. They are not recommended in people with chronic kidney disease unless hemoglobin levels are less than 10 g/dL or they have symptoms of anemia. Their use should be along with parenteral iron. The 2020 Cochrane Anaesthesia Review Group review of Erythropoietin plus iron versus control treatment including placebo or iron for preoperative anaemic adults undergoing non‐cardiac surgery demonstrated that patients were much less likely to require red cell transfusion and in those transfused, the volumes were unchanged (mean difference -0.09, 95% CI -0.23 to 0.05). Pre-op Hb concentration was increased in those receiving 'high dose' EPO, but not 'low dose'.

Hyperbaric oxygen

Treatment of exceptional blood loss (anemia) is recognized as an indication for hyperbaric oxygen (HBO) by the Undersea and Hyperbaric Medical Society. The use of HBO is indicated when oxygen delivery to tissue is not sufficient in patients who cannot be given blood transfusions for medical or religious reasons. HBO may be used for medical reasons when threat of blood product incompatibility or concern for transmissible disease are factors. The beliefs of some religions (ex: Jehovah's Witnesses) may require they use the HBO method. A 2005 review of the use of HBO in severe anemia found all publications reported positive results.

Pre-operative anemia

An estimated 30% of adults who require non-cardiac surgery have anemia. In order to determine an appropriate pre-operative treatment, it is suggested that the cause of anemia be first determined. There is moderate level medical evidence that supports a combination of iron supplementation and erythropoietin treatment to help reduce the requirement for red blood cell transfusions after surgery in those who have pre-operative anemia.

Epidemiology

A moderate degree of iron-deficiency anemia affected approximately 610 million people worldwide or 8.8% of the population. It is slightly more common in females (9.9%) than males (7.8%). Mild iron deficiency anemia affects another 375 million. Severe anaemia is prevalent globally, and especially in sub-Saharan Africa where it is associated with infections including malaria and invasive bacterial infections.

History

Signs of severe anemia in human bones from 4000 years ago have been uncovered in Thailand.